←
Laura Edgington-Mitchell221 posts
Laura Edgington-Mitchell avatar

Laura Edgington-Mitchell

@LauraEM_Lab

Head of the Protease Pathophysiology Lab at the Bio21 Institute, University of Melbourne.

◷ Joined June 2018▧ 60 Photos and videos
Laura Edgington-Mitchell avatar
Laura Edgington-Mitchell@LauraEM_Lab·22 May 2025

The 13th General Meeting of the International Proteolysis Society will be held in Búsios, Brazil Oct 26-30, 2025. Training workshops will be held at the Instituto Oswaldo Cruz Oct 23-23. Register now! Links below. 1/3

Post attachment
Laura Edgington-Mitchell avatar
Laura Edgington-Mitchell@LauraEM_Lab·22 Jun 2025

Congrats to Anna and Marc for the publication of their review article "Nuclear Roles for Canonically Lysosomal Proteases.' Check it here: tandfonline.com/doi/full/10.… #LEMLab

Vergent Bioscience avatar
⟳ Laura Edgington-Mitchell retweeted
Vergent Bioscience@VergentBio·22 May 2025

#News: Phase 2B VISUALIZE study results will be presented by @PennMedicine’s Dr. Sunil Singhal at #ASCO25, demonstrating that intraoperative molecular imaging with abenacianine for injection (VGT-309) during lung surgery has the potential to improve surgical outcomes. More: bit.ly/439aILt

Post attachment
Laura Edgington-Mitchell avatar
Laura Edgington-Mitchell@LauraEM_Lab·22 May 2025

We have travel awards available for early career researchers, and we are seeking nominations for the Ulrich auf dem Keller Young Investigator award for researchers within 6 years of establishing their independent labs. Please apply before June 30 so you don't miss out! 2/3

David R. Liu avatar
⟳ Laura Edgington-Mitchell retweeted
David R. Liu@davidrliu·15 May 2025

In a medical milestone, a customized base editor was developed, characterized in human and mouse cells, tested in mice, studied for safety in non-human primates, cleared by @US_FDA for clinical trial use, manufactured as a complex with an LNP, and dosed into a baby with a severe, rapidly progressing genetic disease... all in an astounding 7 months. Best of all, the infant patient shows apparent benefit. Congratulations to @kiranmusunuru, Rebecca Ahrens-Nicklas, and other team members for this heroic and inspiring effort, which has implications for the hundreds of millions of patients that suffer from thousands of genetic diseases. drive.google.com/file/d/1Jfk…

Post attachment
Lauren Bird avatar
⟳ Laura Edgington-Mitchell retweeted
Lauren Bird@_laurenbird1·25 Apr 2025

Excited to share this story from my PhD, out today in @NatureComms. We show that Coxiella removes cathepsin B to reduce lysosomal hostility and promote bacterial success. This depends on a vacuole established by effector CvpB. nature.com/articles/s41467-0…

Snow Medical avatar
⟳ Laura Edgington-Mitchell retweeted
Snow Medical@SnowMedical·24 Mar 2025

We’re thrilled to welcome our 14th Snow Fellow, Dr Alisa Glukhova @gl_alisa, a structural biologist from @WEHI_research. Alisa’s work focusses on how cells communicate and what happens when those signals go wrong, leading to diseases like cancer. snowmedical.org.au

1:59
Laura Edgington-Mitchell avatar
Laura Edgington-Mitchell@LauraEM_Lab·18 Oct 2024

I am happy to share a another manuscript by @BangyanXu, a fun collaboration with Simon and @Thompson_Chem. We report some new sulfoxonium ylide activity-based probes for cysteine cathepsins. Check it out! pubs.acs.org/doi/10.1021/acs…

Laura Edgington-Mitchell avatar
Laura Edgington-Mitchell@LauraEM_Lab·17 Oct 2024

It's been a big week for this proud supervisor. I am so pleased to announce that @alex_ziegler8 has been awarded the Bill Sawyer Medal, which recognises outstanding achievements of Graduate Researchers in the Dept of Biochem & Pharm. Alex has had a great year and is so deserving!

Post attachment